Literature DB >> 17083857

Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis.

A Manzur1, Arfan ul Bari.   

Abstract

BACKGROUND: The leishmanin skin test (LST) is frequently used for clinical diagnosis of cutaneous leishmaniasis (CL). Although, LST is highly sensitive for CL, no definitive data exists as to how early in the disease does the test becomes positive.
OBJECTIVE: The study was aimed to evaluate the sensitivity of LST in early cases of CL. PATIENTS AND METHODS: One hundred male patients with CL of not more than 2-weeks duration and having parasitologically proven diagnosis were enrolled in this study, carried out in a military hospital in Balochistan, Pakistan. LST was done by intradermal injection of 0.1 ml leishmanin on the volar surface of the forearm. The skin test reaction was read after 48 hours and then at 72 hours if the first reading was negative or marginal. If the initial test was negative, the LST was repeated after every 7 days until a positive reaction was produced. The total time from the onset of skin lesions until a positive LST was obtained was recorded for every patient.
RESULTS: A positive LST was demonstrated in 78/100 patients with skin lesions of <or= 2 weeks duration, thus showing a sensitivity of 78 percent for this short duration. The sensitivity of LST increased to 94 percent and 98 percent for CL lesions of 4 and 6 weeks duration, respectively.
CONCLUSION: LST is sensitive even in those CL patients who present with lesions of very recent onset. Thus the test can be employed with confidence, for the diagnosis of CL, even in early disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17083857

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  9 in total

1.  Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru.

Authors:  Andrea K Boggild; Cesar Miranda-Verastegui; Diego Espinosa; Jorge Arevalo; Vanessa Adaui; Gianfranco Tulliano; Alejandro Llanos-Cuentas; Donald E Low
Journal:  J Clin Microbiol       Date:  2007-09-19       Impact factor: 5.948

2.  Improving serodiagnosis of human and canine leishmaniasis with recombinant Leishmania braziliensis cathepsin l-like protein and a synthetic peptide containing its linear B-cell epitope.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Matheus de Souza Gomes; Daniella Castanheira Bartholomeu; Ricardo Toshio Fujiwara
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

3.  Sporotrichoid leishmaniasis: a cross-sectional clinical, epidemiological and laboratory study in Rio de Janeiro State, Brazil.

Authors:  Livia Martins Veloso de Carvalho; Maria Inês Fernandes Pimentel; Fátima Conceição-Silva; Érica de Camargo Ferreira E Vasconcellos; Cláudia Maria Valete-Rosalino; Marcelo Rosandiski Lyra; Mariza de Matos Salgueiro; Maurício Naoto Saheki; Maria de Fátima Madeira; Eliame Mouta-Confort; Liliane de Fátima Antonio; Aline Fagundes da Silva; Leonardo Pereira Quintella; Sandro Javier Bedoya-Pacheco; Armando de Oliveira Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-06-01       Impact factor: 1.846

4.  Diagnostic accuracy of Enzyme-Linked Immunosorbent Assays to detect anti-Leishmania antibodies in patients with American Tegumentary Leishmaniasis: a systematic review.

Authors:  Andernice Dos Santos Zanetti; Camila Massae Sato; Fabiana Gulin Longhi; Silvana Margarida Benevides Ferreira; Omar Ariel Espinosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-08-19       Impact factor: 1.846

5.  A prospective cohort study of Cutaneous Leishmaniasis due to Leishmania major: Dynamics of the Leishmanin skin test and its predictive value for protection against infection and disease.

Authors:  Jihène Bettaieb; Amine Toumi; Wissem Ghawar; Sadok Chlif; Mariem Nouira; Nabil Belhaj-Hamida; Adel Gharbi; Nissaf Ben-Alaya; Dhafer Laouini; Hechmi Louzir; Koussay Dellagi; Afif Ben Salah
Journal:  PLoS Negl Trop Dis       Date:  2020-08-25

Review 6.  Nanodiagnostics in leishmaniasis: A new frontiers for early elimination.

Authors:  Mallikarjuna Rao Gedda; Prasoon Madhukar; Ashish Shukla; Shyam Lal Mudavath; Onkar Nath Srivastava; Om Prakash Singh; Shyam Sundar
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-11-03

7.  MPLA and AddaVax® Adjuvants Fail to Promote Intramuscular LaAg Vaccine Protectiveness against Experimental Cutaneous Leishmaniasis.

Authors:  Diogo Oliveira-Maciel; Júlio Souza Dos-Santos; Gabriel Oliveira-Silva; Mirian França de Mello; Alessandra Marcia da Fonseca-Martins; Monique Pacheco Duarte Carneiro; Tadeu Diniz Ramos; Luan Firmino-Cruz; Daniel Claudio Oliveira Gomes; Bartira Rossi-Bergmann; Herbert Leonel de Matos Guedes
Journal:  Microorganisms       Date:  2021-06-11

8.  Evaluation of leishmanin skin test reaction in different variants of cutaneous leishmaniasis.

Authors:  Giti Sadeghian; Hengameh Ziaei; Leila Shirani Bidabadi; Mohammad Ali Nilforoushzadeh
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

9.  Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis.

Authors:  Liliane de Fátima Antonio; Aline Fagundes; Raquel Vasconcellos Carvalhaes Oliveira; Priscila Garcia Pinto; Sandro Javier Bedoya-Pacheco; Erica de Camargo Ferreira e Vasconcellos; Maria Cláudia Valete-Rosalino; Marcelo Rosandiski Lyra; Sônia Regina Lambert Passos; Maria Inês Fernandes Pimentel; Armando de Oliveira Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Sep-Oct       Impact factor: 1.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.